Description
EO 14398 -RADIOPHARMACEUTICALS AND TESTING
Base award description: RADIOPHARMACEUTICALS AND WHITE CELL TESTING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-09-18+$0= $0
- Mod P000012026-03-05+$0= $0
- Mod P000022026-06-08+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-09-18 | +$0 | $0 | RADIOPHARMACEUTICALS AND WHITE CELL TESTING |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2026-03-05 | +$0 | $0 | RADIOPHARMACEUTICALS AND WHITE CELL TESTING |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-06-08 | +$0 | $0 | EO 14398 -RADIOPHARMACEUTICALS AND TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI L9WMR4VFJXE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0376 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $233,435 | FY2026 |
| 36C25525N0359 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $221,604 | FY2025 |
| 36C25524N0422 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $54,623 | FY2024 |
| 36C25523P0208 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $124,471 | FY2023 |
| 36C25522N0196 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q527 · MEDICAL- NUCLEAR MEDICINE | $44,952 | FY2022 |
| 36C25521N0128 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $50,002 | FY2021 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0352 | MID-AMERICA ISOTOPES, INC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $1,394,313 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C25524D0051_3600 · retrieved 2026-09-26.